Insulet Corp. Stock
Insulet Corp. Stock
The price for the Insulet Corp. stock decreased slightly today. Compared to yesterday there is a change of -€1.800 (-0.740%).
With 46 Buy predictions and not a single Sell prediction Insulet Corp. is an absolute favorite of our community.
As a result the target price of 317 € shows a positive potential of 30.4% compared to the current price of 243.1 € for Insulet Corp..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Insulet Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Insulet Corp. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Cons
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insulet Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Insulet Corp. | -0.740% | 2.554% | -1.011% | -8.824% | 0.287% | -9.296% | 4.302% |
| Icu Medical Inc. | -0.750% | 3.876% | 8.943% | -16.770% | 8.065% | -16.770% | -23.864% |
| Bio-Rad Labs Inc. A | -1.800% | -3.677% | 3.888% | -20.215% | 3.606% | -36.592% | -47.089% |
| Merit Medical Systems | -0.710% | -1.408% | -4.762% | -29.293% | -5.405% | 10.236% | 50.215% |
Comments
Insulet (NASDAQ:PODD) had its "buy" rating reaffirmed by analysts at UBS Group AG.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) had its price target lowered by analysts at Truist Financial Corporation from $412.00 to $390.00. They now have a "buy" rating on the stock.
Show more
Ratings data for PODD provided by MarketBeat
Insulet (NASDAQ:PODD) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $370.00 price target on the stock.
Show more
Ratings data for PODD provided by MarketBeat
News
Insulet (PODD) Q2 Revenue Jumps 33%
Insulet (NASDAQ:PODD), a medical device company specializing in wearable insulin delivery systems, released its second quarter 2025 earnings on August 7, 2025. The headline news was strong
